In comparison with that in the Sham + shFTO group, FTO expression in the TAC + shFTO group was slightly elevated; however, the difference was not significant, which might be because of a low expression of FTO in myocardial tissues due to shFTO treatment. This evidence concerns the gene FTO and persistent truncus arteriosus.